T-ZELL-REZEPTOREN

European patent · EP3433270 · In force

Register entry

Publication number
EP3433270
Application number
EP17715521
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 22, 2017
Published
Jan 30, 2019
Granted
Sep 20, 2023
Protection ends at the latest
Mar 21, 2037
Next annual fee due
Mar 31, 2027
IPC classes
C07K 14/725 (2006.01)
Priority
GB 201604953 23.03.2016
PCT application
PCT/GB2017/050805 22.03.2017
PCT publication
WO2017/163064 28.09.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Jul 31, 2024

    Change

    Published in Swissreg on 31.07.2024

  4. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  5. Sep 20, 2023

    Granted

    Published in Swissreg on 20.09.2023

Parties

Holder

Immunocore Limited

92 Park Drive Milton Park, Abingdon, Oxfordshire OX14 4RY, GB

Inventor

LI, Yi

Abingdon Oxfordshire OX14 4RY, GB

MAHON, Tara

Abingdon Oxfordshire OX14 4RY, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.